MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
MBX Biosciences, Inc. (MBX)
Company Research
Source: Yahoo! Finance
company focused on the discovery, development and commercialization of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced the issuance of an equity inducement award to Karen Basbaum in connection with her commencement of employment as the company's new Chief Business Officer. The inducement award consisted of non-qualified stock options to purchase an aggregate of 130,000 shares of the company's common stock with an exercise price of $32.29 per share, which is equal to the closing price of the company's common stock as reported by Nasdaq on April 1, 2026. The option has a 10-year term and will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of March 9, 2026, and the remainder vesting in 36 equal monthly installments for the three years thereafter, subject to Ms. Basbaum's continued service. The award is subject to the terms and conditions of the company's 2026 Inducement Plan and the t
Show less
Read more
Impact Snapshot
Event Time:
MBX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MBX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MBX alerts
High impacting MBX Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
MBX
News
- MBX Biosciences to Host In-Person and Virtual Obesity Day on May 11, 2026 to Discuss Expanding Obesity PortfolioGlobeNewswire
- Aaron Wealth Makes a Big Bet on MBX Biosciences With a 1.1 Million Share Purchase [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Aaron Wealth Makes a Big Bet on MBX Biosciences With a 1.1 Million Share Purchase [Yahoo! Finance]Yahoo! Finance
- MBX Biosciences (MBX) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=MBX&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "hold" toMarketBeat
- Does MBX (MBX) Options-Driven Breakout Reveal Deeper Shifts In Its Investment Narrative? [Yahoo! Finance]Yahoo! Finance
MBX
Earnings
- 3/12/26 - Beat
MBX
Sec Filings
- 4/22/26 - Form 144
- 4/22/26 - Form ARS
- 4/22/26 - Form DEFA14A
- MBX's page on the SEC website